The sigma1 receptor is a target for the development of cardioprotective drugs

By afschroeder • October 10, 2025

Maslov LN, Tsirulnikov K, Slidnevskaya AS, Kilin M, Kan A, Grab AE, Gorbunov AS, Singh N. The σ₁receptor is a target for the development of cardioprotective drugs. Life Sci. 2025 Oct 9;381:124012. doi: 10.1016/j.lfs.2025.124012. Epub ahead of print. PMID: 41067303.

Tags: cardiac remodeling, heart, Ischemia/reperfusion;, mitochondria, Nephrology, Publications, sigma(1)-Receptor

Allele-specific HLA-B39 antibody reactivity in a highly sensitized kidney transplant candidate

Du A, Ishaq W, Flores DA, Saquilayan M, Ling C, Muramoto J, Kendall K, Butler CL, Reed EF, Zhang QJ, Barba LM, Sosa RA. Allele-specific[...]

Renal Toxicity of Rosuvastatin: A Case Report

Schulze C, Shye M. Renal Toxicity of Rosuvastatin: A Case Report. Cureus. 2025 Nov 3;17(11):e96013. doi: 10.7759/cureus.96013. PMID: 41356965; PMCID: PMC12675985.

Indoxyl sulfate: clinical implications for anemia management in chronic kidney disease

Rattanasompattikul M, Srithongkul T, Tantisattamo E, Kalantar-Zadeh K, Noppakun K. Indoxyl sulfate: clinical implications for anemia management in chronic kidney disease. Curr Opin Nephrol Hypertens.[...]